Eric Kanowsky

About Eric Kanowsky

Prior to co-founding Entrada Ventures, Eric spent over twenty years as an Angel Investor and Entrepreneur founding, investing in, and working with start-up companies in a variety of industries including medical device, biotech, and enterprise software. During that time, more than a few of those companies have had large IPO and M&A exits ranging from hundreds of millions to billions of dollars in enterprise value.In addition to being an early investor in such companies as Procore (IPO 2021), Truevision Systems (acquired by Alcon 2018), Lunglife.AI (IPO AIM 2021), Apeel Sciences, CytomX (IPO 2015), HG Insights (acquired 2020), and many others, he has also held a variety of operational and leadership positions in early stage ventures. These include having served as Co-founder and Vice President of Operations at Software.com (IPO Chief Operating Officer, Board Member, and Co-founder at Advanced Cardiac Therapeutics (rebranded as EPIX Therapeutics 2018, acquired by Medtronic 2019), and Board Member and CEO at SmartReceipt (acquired 2014). Eric is active within the UCSB Technology Management Program and their New Venture Competition having served as both a mentor and a judge multiple times.

Experience

1. Board Member

   Mixmode

   Mar 2020 — Present

Education

• Indiana University - Kelley School of Business

  MBA

  1990 — 1992

• Rensselaer Polytechnic Institute

  BS, Mechanical Engineering

  1983 — 1987

Skills

• Enterprise Software
• Product Development
• Product Management
• Venture Capital
• Angel Investing
• Corporate Development
• Go-to-Market Strategy
• Software as a Service (Saas)
• Saas
• Strategy
• Strategic Partnerships
• Start-Ups
• Management
• Business Strategy
• Executive Management
• Business Planning
• Mergers & Acquisitions
• Entrepreneurship